Growth Control

生长控制

• 批准号: 7714188
• 负责人: MICHELE PAGANO
• 金额: $ 1.45万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-18 至 2013-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7714188
• 关键词: Animal Model; Area; Clinical; Commit; Development; Enrollment; Exertion; Faculty; Fostering; Funding; Genes; Genetic Transcription; Goals; Grant; Growth; Human; Institutes; Investigator-Initiated Research; Knowledge; Malignant - descriptor; Malignant Neoplasms; Molecular; Mutation; Neoplasms; Pathway interactions; Pattern; Peer Review Organizations; Phase; Publications; Recommendation; Recruitment Activity; Research; Research Personnel; Resource Sharing; Sampling; Scientist; Signal Transduction Pathway; Site; Strategic Planning; Structure; Therapeutic; Time; Translational Research; Tumor Suppressor Genes; Work; base; cohesion; design; experience; instrument; interest; member; neoplastic cell; novel; programs; tumor

The Growth Control Program was created in 2001 as part of the reorganization of the NYU Cancer Institute. In the initial phase of organizing the Program, we found it useful to have co-leaders, Drs. Pagano and Skolnik. After this initial period, the synergetic exertion by two leaders was no longer necessary. Accordingly, since 2003 the Program has been led only by Dr. Pagano. Among the reasons for this change was the recommendation of the last site visitors who concluded that there was undesirable overlap in responsibilities with two co-leaders. The program started with 17 members. However, Dr. Pagano was committed to creating a critical mass around the central theme of the program by broadening its base and developing new initiatives in important areas (e.g., the integration of bench research with translational research and the promotion of productive interactions between basic scientists and clinicians, see sections 8.2.g and 8.2.h). Therefore, he selected a Steering Committee (see below) to solicit new members. The Steering Committee decided to focus on issues beyond the scientific stature of the candidate members, seeking investigators who would truly make a concrete contribution to the objectives of the Program and devote >50% of their time to the scientific themes of the Program. Following several strategic planning sessions, additional scientists whose expertise would advance the program's objectives were enrolled. This growth was also fueled by the new faculty recruitment efforts of the NYUCI. Currently, the program includes 44 members of which 18 (41%) are junior faculty members. Importantly, 17 members of the program (39%) were recruited to NYU after 2002 (see details in the Table below). The extraordinary growth that the Program has experienced in the last four years represents an essential transition period that is expected to maximize programmatic cohesion and foster research interactions. The criteria used for selecting solicited and unsolicited applications for membership in the Growth Control Program include: 1) Demonstrated commitment, expertise and funding in basic and translational cancer-relevant research; 2) Evidence of ongoing collaborative efforts with other investigators in these areas; 3) Commitment to the shared objectives of the Growth Control Program and the NYU Cancer Institute as a whole; 4) Funding from NCI or equivalent national organization for peer-reviewed, cancer-relevant and investigator-initiated research (junior investigators excluded). The membership of the Growth Control Program is reviewed annually by the Steering Committee. Members who fail to participate in the program activities during the previous year are presented with an opportunity to resign or increase their participation.

增长控制计划是在2001年创建的，作为纽约大学癌症的重组的一部分 研究所。在组织该计划的初始阶段，我们发现拥有共同领导者DRS很有用。帕加诺 和Skolnik。在此初期之后，不再需要两个领导人的协同努力。 因此，自2003年以来，该计划仅由Pagano博士领导。造成这种变化的原因之一 是最后一个现场访问者的建议，他们得出结论认为不良重叠 两个共同领导者的责任。该计划始于17名成员。但是，Pagano博士是 致力于通过扩大其基础和 在重要领域制定新举措（例如，基准研究与转化 研究和促进基础科学家与临床医生之间的生产互动，请参阅各节 8.2.g和8.2.h）。因此，他选择了一个指导委员会（见下文）来征求新成员。这 指导委员会决定将重点放在候选人的科学地位以外的问题上 寻求真正将为该计划的目标做出具体贡献的调查员 将> 50％的时间投入到该计划的科学主题上。遵循几个战略计划 会议，其他科学家的专业知识将促进该计划的目标。这 Nyuci的新教师招聘工作也推动了增长。目前，该程序 包括44名成员，其中18名（41％）是初级教职员工。重要的是，17名成员 计划（39％）在2002年之后招募到纽约大学（请参阅下表中的详细信息）。非凡的增长 该计划在过去四年中所经历的代表了一个基本过渡期 期望最大化程序化凝聚力并促进研究相互作用。用于 在增长控制计划中选择征求和主题的申请包括：1） 在基本和转化的与癌症有关的研究中表现出承诺，专业知识和资金； 2） 与这些领域其他研究人员进行的合作努力的证据； 3）致力于 增长控制计划和纽约大学癌症研究所的共同目标； 4）资金 NCI或同等评估，与癌症相关和研究人员发起的同等国家组织 研究（不包括初级研究人员）。审查了增长控制计划的成员资格 每年由指导委员会。未能参加计划活动的成员 上一年有机会辞职或增加参与。